• We are catalysts for innovation, commercialising next-generation technologies developed by

    The University of Manchester’s world-class research base

    • £360m+ invested by venture funders

    • 40+ spin-out companies created

    • 7,500+ licences and IP partnerships concluded

    • 4,000+ invention disclosures received

    • £115m+ IP and R&D revenue generated for the University

  • We are catalysts for innovation, commercialising next-generation technologies developed by The University of Manchester’s world-class research base

    • £300m+ invested by venture funders since 2004

    • 40+ spin-out companies created

    • 4,800+

      licences and IP partnerships concluded

    • 3,700+ invention disclosures received

    • 1,300+ jobs generated across various industry sectors

    • £105m+ IP and R&D revenue generated for the University

Archive for June, 2014

STORM CEO appointed as UMIP Social Enterprise Ambassador

Dr Gill Green, CEO of Self-harm Mitigation and Postvention training service, STORM Skills Training CIC, has been appointed Social Enterprise Ambassador to UMIP.

As part of her role, she will help advise the founders and teams behind new social enterprises from the University on how best to prepare for their journey – offering tips and hints gleaned from her many years’ of experience in running a social enterprise.

Tony Walker, Director of Enterprise and Business Development at UMIP, commented: “We are delighted to add Gill’s considerable experience and credibility to help further our social enterprise agenda here at UMIP. It has been an exceptional couple of years of development, we have evaluated 108 socially innovative ideas, and with the support of our partners UnLtd made awards to over 25 budding social entrepreneurs across the campus and have exciting new spin-out companies in this area. The Ambassador role further demonstrates our commitment to building on our award winning programme to address social, civic and environmental issues by unleashing the creative power of our staff, students and recent graduates.”

Dr Green will help stimulate new social enterprises among academics and staff at presentations, training and development events run by UMIP, as well as helping to set up a number of quarterly round table events with early-stage projects, academics and social entrepreneurs.

These will focus on stimulating self-help, keeping interested parties appraised of high-profile issues which might affect social enterprises and helping organisations to develop a view of best practice.

Commenting on her appointment, Dr Green said: “I’m thrilled to be invited to take the post, which will see social enterprises represented with an ambassador alongside those already in place to support spin-outs and licensing.

“I can’t wait to use my experiences with STORM to help others and look forward to bringing together early-stage social enterprises to discuss best practice and relevant issues.”

Dr Green’s STORM enterprise, a UMIP spin-out, has been trading independently of the University for just under two years and in that time has grown considerably. It now employs two full time staff, three part time employees and 20 consultants who deliver the training.

STORM also recently launched its flagship campaign – ‘Hey, are you OK?’ (#HeyareyouOK?) – which aims to help people recognise distress in themselves and others, and learn how to seek and offer help when confronted with these situations.

For more information about STORM, please see www.stormskillstraining.com

Follow STORM on Twitter @STORM_CIC

Johnson & Johnson Innovation team up with Manchester scientists

As part of a strategy to explore the emerging science around the human microbiome and its impact across several areas of health and disease, Johnson & Johnson Consumer & Personal Products Worldwide and Johnson & Johnson Innovation have established a collaboration with scientists from The University of Manchester.

The collaboration will explore potential applications of probiotic extracts for prevention and treatment of skin, oral, and respiratory conditions.

Dr Catherine O’Neill, from the University’s Institute of Inflammation and Repair, and Dr Andrew McBain, from Manchester Pharmacy School, will lead on the research project with Johnson & Johnson Innovation.

Dr O’Neill said: “It’s exciting to be working with such a massive global player who we hope will really help us to develop products which will bring benefits to patients.

“This collaboration will help us co-develop a piece of technology established here in Manchester which uses probiotics – or friendly bacteria – on the skin and hopefully take this to market.”

The agreement underscores the approach Johnson & Johnson Innovation is taking to establish scientific collaborations in areas that span its pharmaceutical, medical device and diagnostics and consumer businesses.

School of Physics and Astronomy Industry Engagement Day

Thursday, 10 July 2014 from 09:30 to 16:00

The University of Manchester, Schuster Building, M13 9PL

You are personally invited to attend a showcase of the Technology Translation Fellow resource and associated University of Manchester expertise within the School of Physics & Astronomy

Join us to find out more about our research capability, funding opportunities, network with key academics, hear case studies from companies engaging with the University and meet the Business Engagement network(Business Engagement / Knowledge Exchange / UMIP )

Physics and Astronomy research is increasingly growing in importance as a key contributor to economic growth across a whole host of industry sectors including:

>sensors and instrumentation for medical device applications and new microelectronics and complex 3d structures for high value manufacturing

>new algorithms and processing capability for solving complex software, web analytics and big data problems

>lasers for modern society, used in barcode scanners, hair removal, CD players and many industrial processes

>opportunities for developing new electronics, computing and software systems and infrastructure for the Square Kilometre Array, one of the largest science facilities ever constructed

This event is aimed at Small to Medium Enterprises (SMEs) and larger organisations that want to know more about collaboration or accessing our support and expertise.

There will also be the opportunity to tour some of our world class facilities such as that of the Manchester Particle Physics group who specialises in the development and production of detectors which record the passage of charged particles. Visitors to the lab will see equipment for producing and testing a variety of different types of tracking detectors, from large-scale wire chambers to ultra-high-precision solid state pixel detectors with resolutions on the order of a few microns.

Confirmed speakers include:

The University of Manchester Alick Deacon, Physics and Astronomy Technology Translation Fellow

UMIP Tony Walker, Director of Enterprise and Business Development

National Graphene Institute James Barker, Business Director

Science and Technology Facilities Council (STFC) Phil Tait

Technology Strategy Board (TSB) Rob Heathman, Research Base Liaison Manager

Keith Grainge, Lead of the SKA Signal and Data Transport consortium

Register here and come along to our event on Thursday, 10 July 2014




UMIP finalists at Business Impact Awards


l to r: Allan Prits (UMI3), Clare Arkwright (UMIP), Steve Mould, Dr Joanne Tippett (Ketso)

The awards, which recognise and celebrate the impact of innovation, were held at the Association’s Gala Dinner in Cardiff on12th June. UMIP was recognised by the judges for its social business, Ketso Ltd, which sells a hands-on kit for creative engagement.

Dr Joanne Tippett invented Ketso whilst working with villagers in rural Africa, planning for the future of their area. Ketso literally means ‘action’ in Lesotho. Her research at The University of Manchester enabled her to test and develop the toolkit with a wide range of stakeholders. In 4 years, Joanne took Ketso from a hand-made kit to a saleable product and in 2009 Ketso was launched as a social business.

The kit is more tactile and visually appealing than traditional flip charts and sticky notes. This makes it highly inclusive, a factor in the Scottish Government choosing it as the key engagement tool for developing its 2013 Refugee Integration Strategy. Ketso generates social value throughout its supply chain, with fairtrade components that are assembled in a supportive workplace in the UK.

Ketso has demonstrated clear impact in enterprise development, strategy and change management, health and wellbeing, environment, community planning, teaching and learning, research and engagement with the vulnerable (refugees, mentally ill, learning disabled). Ketso is the only documented spin-off company from ESRC-funded research, and is used in 41 countries, with more than 350 unique customers and at least 19,800 participants in workshops.

Joanne commented: “I was delighted to be selected as a finalist and to have an opportunity to discuss research impact at the Awards Ceremony. Being selected pays tribute to the role that UMIP has played in supporting an innovative new model for a social business from social science research. It is also great to have recognition for the impact that Ketso is already having and its potential to go on to inspire more people to engage and make positive changes worldwide.”

UMIP’s Director of Operations, Dr Rich Ferrie, added: “It is an honour to have been selected as finalists by PraxisUnico. Ketso as an exciting social venture whose main product has impacted the lives of thousands of people internationally. It’s been our pleasure to provide Joanne Tippett and Ketso with a platform on which to grow.”

For more information on Ketso, please visit www.ketso.com

The Impact Awards logo

Award-winning healthcare spin-out receives private equity funding

Curapel (Scotland) Limited, the creator of a range of revolutionary and patented skin care technologies has received £200,000, the first tranche of a potential £350,000 investment, of private equity funding from Glasgow-based Lancaster Capital.

The company, which was spun out of The University of Manchester by its agent for intellectual property commercialisation (UMIP), is based on award-winning translational research originating from the Faculty of Medicine. It will use the financial backing provided by Lancaster to reach key milestones on the path towards clinical trials, consumer studies and commercialisation.

Commenting on the receipt of the funding, Dr Neil Gibbs and Dr Cath O’Neill, the joint founders of Curapel and finalists for the ‘Commercial Innovator of the Year, 2014’ said:

“We’re delighted to have received this initial funding, which will enable Curapel to progress its technology and products towards partnering and the commercialisation of new, safe and effective treatment for patients”.

Curapel’s technologies are targeted at the large, unmet clinical need within the dermatology and the wider skin care sector for safe and effective treatments for eczema, psoriasis and disorders of skin pigmentation.

The initial cash injection from Lancaster Capital, represents first round funding and the company will be seeking additional funds to take forward its three programmes through further development and clinical testing with the aim of partnering with industry participants to commercialise the products internationally.